208 related articles for article (PubMed ID: 15312391)
21. [Effect of intraperitoneal chemotherapy with implantable reservoir against unresectable gastric cancer].
Kawasaki S; Nagai K; Maruyama S; Murakami M; Yosizane K; Morokoshi Y; Kawai K; Yamamoto M; Soda M; Misumi T
Gan To Kagaku Ryoho; 1995 Feb; 22(2):215-20. PubMed ID: 7857095
[TBL] [Abstract][Full Text] [Related]
22. Weekly infusional high-dose fluorouracil (HD-FU), HD-FU plus folinic acid (HD-FU/FA), or HD-FU/FA plus biweekly cisplatin in advanced gastric cancer: randomized phase II trial 40953 of the European Organisation for Research and Treatment of Cancer Gastrointestinal Group and the Arbeitsgemeinschaft Internistische Onkologie.
Lutz MP; Wilke H; Wagener DJ; Vanhoefer U; Jeziorski K; Hegewisch-Becker S; Balleisen L; Joossens E; Jansen RL; Debois M; Bethe U; Praet M; Wils J; Van Cutsem E; ;
J Clin Oncol; 2007 Jun; 25(18):2580-5. PubMed ID: 17577037
[TBL] [Abstract][Full Text] [Related]
23. Weekly infusional high-dose 5-fluorouracil and leucovorin and biweekly cisplatin: a convenient treatment option in advanced gastric cancer.
Kundel Y; Purim O; Figer A; Stemmer SM; Tichler T; Sulkes J; Sulkes A; Brenner B
Med Sci Monit; 2008 Apr; 14(4):CR190-5. PubMed ID: 18376346
[TBL] [Abstract][Full Text] [Related]
24. [Treatment for advanced gastric cancer with positive lavage cytology-systemic versus intraperitoneal chemotherapy].
Iwasaki Y; Ohashi M; Nunobe S; Iwanaga T; Iwagami S; Takahashi K; Yamaguchi T; Matsumoto H; Nakano D
Gan To Kagaku Ryoho; 2008 Nov; 35(12):2009-11. PubMed ID: 19106506
[TBL] [Abstract][Full Text] [Related]
25. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery.
Jin J; Liao Z; Zhang Z; Ajani J; Swisher S; Chang JY; Jeter M; Guerrero T; Stevens CW; Vaporciyan A; Putnam J; Walsh G; Smythe R; Roth J; Yao J; Allen P; Cox JD; Komaki R
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):427-36. PubMed ID: 15380576
[TBL] [Abstract][Full Text] [Related]
26. Prospective randomized trial of short-term neoadjuvant chemotherapy for advanced gastric cancer.
Imano M; Itoh T; Satou T; Sogo Y; Hirai H; Kato H; Yasuda A; Peng YF; Shinkai M; Yasuda T; Imamoto H; Okuno K; Shiozaki H; Ohyanagi H
Eur J Surg Oncol; 2010 Oct; 36(10):963-8. PubMed ID: 20638818
[TBL] [Abstract][Full Text] [Related]
27. Adjuvant chemotherapy with cisplatin, etoposide, fluorouracil and leucovorin for gastric carcinoma.
Papadakou M; Xydakis E; Bonios M; Makropoulou E; Boukis C; Kakavoulis T; Karaliotas C; Panagos G
J BUON; 2006; 11(3):285-9. PubMed ID: 17309151
[TBL] [Abstract][Full Text] [Related]
28. [Clinical effect of intraperitoneal hyperthermochemotherapy on the survival rate for advanced gastric cancer patients].
Kobayashi K; Fujimoto S; Shrestha RD; Kokubun M; Kiuchi S; Konno C; Takahashi M; Ohta M; Okui K
Gan To Kagaku Ryoho; 1990 Aug; 17(8 Pt 2):1617-21. PubMed ID: 2117895
[TBL] [Abstract][Full Text] [Related]
29. [Evaluation of neoadjuvant chemotherapy with paclitaxel, 5-fluorouracil and cisplatin for advanced gastric cancer with pyloric stenosis].
Yamaguchi K; Nakagawa S; Yabusaki H; Nashimoto A
Gan To Kagaku Ryoho; 2007 Dec; 34(13):2241-4. PubMed ID: 18079622
[TBL] [Abstract][Full Text] [Related]
30. Clinical efficacy of type-B ultrasound-guided intraperitoneal hyperthermic chemoperfusion combined with systemic chemotherapy in advanced gastric cancer patients with malignant ascites.
Lu C; Li L; Luo Z; Cui Y; Fu P; Zhou J; Ma N; Zhou Y
Neoplasma; 2016; 63(2):299-303. PubMed ID: 26774152
[TBL] [Abstract][Full Text] [Related]
31. Feasibility study of postoperative intraperitoneal hyperthermochemotherapy by radiofrequency capacitive heating system for advanced gastric cancer with peritoneal seeding.
Mochiki E; Shioya M; Sakurai H; Andoh H; Ohno T; Aihara R; Asao T; Kuwano H
Int J Hyperthermia; 2007 Sep; 23(6):493-500. PubMed ID: 17952763
[TBL] [Abstract][Full Text] [Related]
32. Paclitaxel and leucovorin-modulated infusional 5-fluorouracil combination chemotherapy for metastatic gastric cancer.
Cho BC; Kim JH; Kim CB; Sohn JH; Choi HJ; Lee YC; Ahn JB
Oncol Rep; 2006 Mar; 15(3):621-7. PubMed ID: 16465422
[TBL] [Abstract][Full Text] [Related]
33. 5-fluorouracil, mitomycin-C, and polysaccharide-K adjuvant chemoimmunotherapy for locally advanced gastric cancer: the prognostic significance of frequent perineural invasion.
Choi JH; Kim YB; Lim HY; Park JS; Kim HC; Cho YK; Han SW; Kim MW; Joo HJ
Hepatogastroenterology; 2007; 54(73):290-7. PubMed ID: 17419278
[TBL] [Abstract][Full Text] [Related]
34. [A randomized controlled trial with methotrexate (MTX), 5-fluorouracil (5-FU) and pirarubicin (THP) vs 5-FU alone in advanced or recurrent gastric carcinoma. Tokai Hokuriku THP Study Group].
Yamamura Y; Miyazaki I; Ogawa M; Yonemura Y; Tanemura H; Kito T; Hamajima N; Saji S; Kosaka T
Gan To Kagaku Ryoho; 1998 Aug; 25(10):1543-8. PubMed ID: 9725047
[TBL] [Abstract][Full Text] [Related]
35. Advanced gastric cancer with or without peritoneal carcinomatosis treated with hyperthermic intraperitoneal chemotherapy: a single western center experience.
Scaringi S; Kianmanesh R; Sabate JM; Facchiano E; Jouet P; Coffin B; Parmentier G; Hay JM; Flamant Y; Msika S
Eur J Surg Oncol; 2008 Nov; 34(11):1246-52. PubMed ID: 18222622
[TBL] [Abstract][Full Text] [Related]
36. Postoperative immunochemotherapy (BCG + 5-FU) in advanced gastric cancer.
Popiela T; Zembala M; Kulig J; Czupryna A; Uracz W
Anticancer Res; 1988; 8(6):1423-7. PubMed ID: 3064717
[TBL] [Abstract][Full Text] [Related]
37. Treatment outcomes of oxaliplatin, 5-FU, and leucovorin as salvage therapy for patients with advanced or metastatic gastric cancer: a retrospective analysis.
Seo HY; Kim DS; Choi YS; Sung HJ; Park KH; Choi IK; Kim SJ; Oh SC; Seo JH; Choi CW; Kim BS; Shin SW; Kim YH; Kim JS
Cancer Chemother Pharmacol; 2009 Feb; 63(3):433-9. PubMed ID: 18398608
[TBL] [Abstract][Full Text] [Related]
38. A pilot study of preoperative and postoperative chemotherapy in patients with operable gastric cancer: Australasian Gastrointestinal Trials Group Study 9601.
Findlay M; Storey D; Gebski V; Hargreaves C; Cullingford G; Boyer M; Trotter J; Archer S; Davidson A; Johnston P; Yuen J; Dhillon H; Della-Fiorentina S; Richardson G; Truskett P; Goldstein D;
ANZ J Surg; 2007 Apr; 77(4):247-52. PubMed ID: 17388828
[TBL] [Abstract][Full Text] [Related]
39. [Evaluation of a novel adjuvant chemotherapy for non-resectable advanced gastric cancer].
Wang J; Chen J; Wang S
Zhonghua Zhong Liu Za Zhi; 1997 Jan; 19(1):65-8. PubMed ID: 10743061
[TBL] [Abstract][Full Text] [Related]
40. [Clinical evaluation of anticancer effect of methionine-depleting total parenteral nutrition with 5-fluorouracil and/or mitomycin C].
Goseki N; Maruyama M; Nagai K; Kando F; Endo M; Shimoju K; Wada Y
Gan To Kagaku Ryoho; 1995 Jul; 22(8):1028-35. PubMed ID: 7611753
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
